Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

PHATPHAT
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in PHATHOM PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 1.8M shares of PHAT (PHATHOM PHARMACEUTICALS INC), worth $19.3M as of 2026-Q2. The position was increased (+183.9% shares). PHAT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$19.3M

Current Shares

1.8M

Total Value Change

+$15.9M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+183.9%
$19.3M0.0%$10.85
46
2026-Q1
Increased
626,196
+59.7%
$7M0.0%$11.05
39
2025-Q4
Increased
392,045
+157.9%
$6.5M0.0%$16.92
44
2025-Q3
Decreased
152,032
-21.0%
$1.8M0.0%$11.33
0
2025-Q2
Increased
192,526
+2.5%
$1.8M0.0%$9.74
26
2025-Q1
Decreased
187,874
-54.4%
$1.2M0.0%$6.60
0
2024-Q4
New
412,262
-
$3.3M0.0%$8.00
37

Other major holders of PHAT: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used